somatropin vs ipamorelin Sermorelin: Decoding The Differences In Peptide Therapies HGH vs CJC/Ipamorelin vs IGF-1

CJC-1295 (No DAC) is a GHRH analogue that stimulates pituitary somatotrophs, while Ipamorelin is a selective ghrelin receptor (GHS-R1a) agonist that promotes GH release through a distinct, independent pathway

Draw 1.0 mL of bacteriostatic water, swirl gently until dissolved, and store at 28 C protected from light

[Read More]

Which one suits you comes down to what you want to achieve, how you prefer to dose, and what your provider recommends

CJC-1295 Clinical Evidence The Foundation for GH Amplification In two randomised, placebo-controlled, double-blind clinical trials in healthy subjects aged 2161 years, subcutaneous administration of CJC-1295 produced dose-dependent increases in mean plasma GH concentrations of 2 to 10-fold for 6 days or more, and mean plasma IGF-1 concentrations of 1.5 to 3-fold for 911 days

Combination with other treatments